Samuel Stanley, MD
Stony Brook University
Samuel L. Stanley Jr., MD became the fifth President of Stony Brook University on July 1, 2009. A highly distinguished biomedical researcher, Samuel Stanley was among the nation’s highest recipients of support from the National Institutes of Health (NIH) for his research focusing on enhanced defense against
emerging infectious diseases. He is an expert in the biological mechanisms that cells employ when responding to infectious agents such as parasites, bacteria, and viruses, a process commonly called the inflammatory response.
As chair of Brookhaven Science Associates, which co-manages Brookhaven National Laboratory with Battelle Memorial Institute, Dr. Stanley joins a select group of leaders from academic institutions such as Princeton, Stanford, the University of California-Berkeley, and the University of Chicago, in co-managing and collaborating with a national laboratory. He serves on the SUNY Strategic Planning Steering Committee and on the boards of Cold Spring Harbor Laboratory, the SUNY Research Foundation, Goodwill Industries of Greater NY and NJ, and the Long Island Association. He is a member of the National Advisory Allergy and Infectious Diseases Council at the NIH and the NIH Directors Blue Ribbon Panel on the National Emerging Infectious Diseases Laboratories. Dr. Stanley serves as an ambassador for the Paul G. Rogers Society for Global Health Research.
Dr. Stanley is a champion of academic and industry collaborations. He continues to work as an advocate for federal funding of basic research, working through organizations such as the AAU and The Science Coalition, to promote the critical role of university research in innovation and discovery.